Cargando…

PET Analysis of Dopaminergic Neurodegeneration in Relation to Immobility in the MPTP-Treated Common Marmoset, a Model for Parkinson’s Disease

BACKGROUND: Positron Emission Tomography (PET) measurement was applied to the brain of the common marmoset, a small primate species, treated with 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP). The marmoset shows prominent Parkinson’s disease (PD) signs due to dopaminergic neural degeneration....

Descripción completa

Detalles Bibliográficos
Autores principales:	Ando, Kiyoshi, Obayashi, Shigeru, Nagai, Yuji, Oh-Nishi, Arata, Minamimoto, Takafumi, Higuchi, Makoto, Inoue, Takashi, Itoh, Toshio, Suhara, Tetsuya
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2012
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3466292/ https://www.ncbi.nlm.nih.gov/pubmed/23056291 http://dx.doi.org/10.1371/journal.pone.0046371

Ejemplares similares

Imaging extra-striatal dopamine D2 receptors in a maternal immune activation rat model
por: Oh-Nishi, Arata, et al.
Publicado: (2022)

D(1)- and D(2)-like receptors differentially mediate the effects of dopaminergic transmission on cost–benefit evaluation and motivation in monkeys
por: Hori, Yukiko, et al.
Publicado: (2021)

Chemogenetic activation of nigrostriatal dopamine neurons in freely moving common marmosets
por: Mimura, Koki, et al.
Publicado: (2021)

Evaluation of [(11)C]oseltamivir uptake into the brain during immune activation by systemic polyinosine-polycytidylic acid injection: a quantitative PET study using juvenile monkey models of viral infection
por: Seki, Chie, et al.
Publicado: (2014)

Lactoferrin ameliorates dopaminergic neurodegeneration and motor deficits in MPTP-treated mice
por: Xu, Shuang-Feng, et al.
Publicado: (2018)

Interleukin-4 Protects Dopaminergic Neurons In vitro but Is Dispensable for MPTP-Induced Neurodegeneration In vivo
por: Hühner, Laura, et al.
Publicado: (2017)

Inhibitory effect of thiacremonone on MPTP-induced dopaminergic neurodegeneration through inhibition of p38 activation
por: Hwang, Chul Ju, et al.
Publicado: (2016)

Segmented Iba1-Positive Processes of Microglia in Autism Model Marmosets
por: Sanagi, Tomomi, et al.
Publicado: (2019)

Signaling Incentive and Drive in the Primate Ventral Pallidum for Motivational Control of Goal-Directed Action
por: Fujimoto, Atsushi, et al.
Publicado: (2019)

Antiparkinsonian effects of the "Radiprodil and Tozadenant" combination in MPTP-treated marmosets
por: Michel, Anne, et al.
Publicado: (2017)

MPTP-driven NLRP3 inflammasome activation in microglia plays a central role in dopaminergic neurodegeneration
por: Lee, Eunju, et al.
Publicado: (2018)

Altered detrusor contractility in MPTP-treated common marmosets with bladder hyperreflexia
por: Pritchard, Sara, et al.
Publicado: (2017)

Tat-Fused Recombinant Human SAG Prevents Dopaminergic Neurodegeneration in a MPTP-Induced Parkinson’s Disease Model
por: Sohn, Eun Jeong, et al.
Publicado: (2014)

Brain-specific NRSF deficiency aggravates dopaminergic neurodegeneration and impairs neurogenesis in the MPTP mouse model of Parkinson’s disease
por: Huang, Dongping, et al.
Publicado: (2019)

Galectin-9/Tim-3 pathway mediates dopaminergic neurodegeneration in MPTP-induced mouse model of Parkinson’s disease
por: Peng, Qinyu, et al.
Publicado: (2022)

Depletion of microglia augments the dopaminergic neurotoxicity of MPTP
por: Yang, Xiaoxia, et al.
Publicado: (2018)

Chemogenetic dissection of the primate prefronto-subcortical pathways for working memory and decision-making
por: Oyama, Kei, et al.
Publicado: (2021)

Hydration level is an internal variable for computing motivation to obtain water rewards in monkeys
por: Minamimoto, Takafumi, et al.
Publicado: (2012)

Partial Depletion of Peripheral M1 Macrophages Reverses Motor Deficits in MPTP-Treated Mouse by Suppressing Neuroinflammation and Dopaminergic Neurodegeneration
por: Yan, Aijuan, et al.
Publicado: (2018)

Development of TASP0410457 (TASP457), a novel dihydroquinolinone derivative as a PET radioligand for central histamine H(3) receptors
por: Koga, Kazumi, et al.
Publicado: (2016)

Differential effects of dopaminergic drugs on spontaneous motor activity in the common marmoset following pretreatment with a bilateral brain infusion of 6-hydroxydopamine
por: Ando, Kiyoshi, et al.
Publicado: (2017)

Conscious Immobility
por: de M. Rudolf, G.
Publicado: (1964)

Immobility of the Jaws
Publicado: (1871)

Chemogenetic attenuation of cortical seizures in nonhuman primates
por: Miyakawa, Naohisa, et al.
Publicado: (2023)

Pentatrichomonas hominis in laboratory-bred common marmosets
por: Inoue, Takashi, et al.
Publicado: (2015)

The Monoamine Re-Uptake Inhibitor UWA-101 Improves Motor Fluctuations in the MPTP-Lesioned Common Marmoset
por: Huot, Philippe, et al.
Publicado: (2012)

Immobility or Closure of the Jaw
por: Westmoreland, W. F.
Publicado: (1876)

Immobility Following Influenza
por: Hoskins, W. Horace
Publicado: (1895)

The role of the MYD88-dependent pathway in MPTP-induced brain dopaminergic degeneration
por: Drouin-Ouellet, Janelle, et al.
Publicado: (2011)

TRH Analog, Taltirelin Protects Dopaminergic Neurons From Neurotoxicity of MPTP and Rotenone
por: Zheng, Cong, et al.
Publicado: (2018)

Single caudate neurons encode temporally discounted value for formulating motivation for action
por: Hori, Yukiko, et al.
Publicado: (2021)

PET imaging-guided chemogenetic silencing reveals a critical role of primate rostromedial caudate in reward evaluation
por: Nagai, Yuji, et al.
Publicado: (2016)

Sigma-1 receptor deficiency reduces MPTP-induced parkinsonism and death of dopaminergic neurons
por: Hong, J, et al.
Publicado: (2015)

Smilagenin Protects Dopaminergic Neurons in Chronic MPTP/Probenecid—Lesioned Parkinson’s Disease Models
por: He, Xuan, et al.
Publicado: (2019)

Antibiotic-induced microbiome depletion protects against MPTP-induced dopaminergic neurotoxicity in the brain
por: Pu, Yaoyu, et al.
Publicado: (2019)

Synuclein Proteins in MPTP-Induced Death of Substantia Nigra Pars Compacta Dopaminergic Neurons
por: Goloborshcheva, Valeria V., et al.
Publicado: (2022)

ON THE MECHANISM OF TONIC IMMOBILITY IN VERTEBRATES
por: Hoagland, Hudson
Publicado: (1928)

Partial Immobility of the Orbicularis Oris
Publicado: (1849)

Challenging the thorium-immobility paradigm
por: Nisbet, Haylea, et al.
Publicado: (2019)

Immobility in the Treatment of Diseases of Extremities
por: Williams, W. L.
Publicado: (1895)

Cannot write session to /tmp/vufind_sessions/sess_0vsssut9ca7m7g3chbscba2p4r